ES2128043T3 - Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral. - Google Patents

Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral.

Info

Publication number
ES2128043T3
ES2128043T3 ES95908504T ES95908504T ES2128043T3 ES 2128043 T3 ES2128043 T3 ES 2128043T3 ES 95908504 T ES95908504 T ES 95908504T ES 95908504 T ES95908504 T ES 95908504T ES 2128043 T3 ES2128043 T3 ES 2128043T3
Authority
ES
Spain
Prior art keywords
bis
amidinobencimidazoles
preparation
retroviral integrase
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95908504T
Other languages
English (en)
Inventor
Christine C Dykstra
Ronald I Swanstrom
Richard R Tidwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
University of North Carolina System
Original Assignee
University of North Carolina at Chapel Hill
University of North Carolina System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill, University of North Carolina System filed Critical University of North Carolina at Chapel Hill
Application granted granted Critical
Publication of ES2128043T3 publication Critical patent/ES2128043T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thin Film Transistor (AREA)
  • Saccharide Compounds (AREA)
  • Recrystallisation Techniques (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Metal-Oxide And Bipolar Metal-Oxide Semiconductor Integrated Circuits (AREA)

Abstract

SE PRESENTA UN METODO PARA INHIBIR LA INTEGRASA RETROVIRAL EN UN SUJETO EN NECESIDAD DEL TRATAMIENTO. EL METODO COMPRENDE LA ADMINISTRACION AL SUJETO DE UNA CANTIDAD INHIBIDORA DE LA INTEGRASA RETROVIRAL DE UN COMPUESTO DE BIS-BENCIMIDAZOLA, TAL COMO BIS[5-AMIDINO-2-5-BENZIMIDAZOLIL]METANO, 1,2-BIS[5-AMIDINO2-BENZIMIDAZOLIL]ETANO, 1,2-BIS[5-AMIDINO-2-BENZIMIDAZOLIL]ETANO O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DE LOS MISMOS. TAMBIEN SE PRESENTA UN METODO PARA COMBATIR LAS INFECCIONES RETROVIRALES.
ES95908504T 1994-01-20 1995-01-18 Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral. Expired - Lifetime ES2128043T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/185,079 US6815461B1 (en) 1994-01-20 1994-01-20 Method of inhibiting retroviral integrase

Publications (1)

Publication Number Publication Date
ES2128043T3 true ES2128043T3 (es) 1999-05-01

Family

ID=22679488

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95908504T Expired - Lifetime ES2128043T3 (es) 1994-01-20 1995-01-18 Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral.

Country Status (11)

Country Link
US (1) US6815461B1 (es)
EP (1) EP0739202B1 (es)
JP (1) JP3306830B2 (es)
AT (1) ATE174508T1 (es)
AU (1) AU675386B2 (es)
BR (1) BR9506552A (es)
CA (1) CA2179015C (es)
DE (1) DE69506686T2 (es)
ES (1) ES2128043T3 (es)
NZ (2) NZ335226A (es)
WO (1) WO1995019772A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562854B2 (en) 1994-12-14 2003-05-13 Axys Pharmaceuticals, Inc. Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
US6255091B1 (en) 1995-04-28 2001-07-03 Axys Pharmaceuticals, Inc. Potentiating metal mediated serine protease inhibitors with cobalt or zinc ions
US5693515A (en) * 1995-04-28 1997-12-02 Arris Pharmaceutical Corporation Metal complexed serine protease inhibitors
CA2281927C (en) 1997-02-25 2004-01-27 Christopher J. Michejda Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
US5935982A (en) * 1997-02-28 1999-08-10 The University Of North Carolina At Chapel Hill Methods of treating retroviral infection and compounds useful therefor
WO1998045275A1 (en) * 1997-04-07 1998-10-15 Axys Pharmaceuticals Corporation Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
FR2766822B1 (fr) * 1997-07-30 2001-02-23 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6150379A (en) * 1997-11-26 2000-11-21 Axys Pharmaceuticals, Inc. Compounds and compositions as anticoagulants
WO1999026933A1 (en) * 1997-11-26 1999-06-03 Axys Pharmaceuticals, Inc. Substituted amidinoaryl derivatives and their use as anticoagulants
SG74717A1 (en) 1998-04-10 2000-08-22 Japan Tobacco Inc Amidine compound
DK1176193T3 (da) * 1999-05-13 2012-09-10 Japan Science & Tech Agency Hæmmere af virusinfektion, som angriber den n-terminale region af integrase
ATE256666T1 (de) 1999-06-04 2004-01-15 Elan Pharma Int Ltd Zusammensetzungen und methoden zur verhinderung des zelltods
US6774144B1 (en) 1999-11-01 2004-08-10 The University Of North Carolina At Chapel Hill Methods and formulations for the treatment of infectious bursal disease in avian subjects
WO2001032159A2 (en) * 1999-11-01 2001-05-10 The University Of North Carolina At Chapel Hill Methods and formulations for the treatment of infectious bursal disease in avian subjects
US7262223B2 (en) 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
EP2120952A4 (en) * 2007-01-15 2011-09-21 Us Of America As Represented By The Secretary Of The Army On Behalf Of The U S Army Res Inst Of Infe ANTIVIRAL COMPOUNDS AND METHOD FOR THEIR USE
US8207209B2 (en) * 2007-10-24 2012-06-26 Functional Genetics, Inc. Methods of inhibiting viral infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA708089B (en) * 1969-12-29 1971-08-25 Abbott Lab Bis-benzimidazole derivatives
US4619942A (en) * 1982-04-08 1986-10-28 University Of North Carolina Inhibition of Respiratory Syncytial virus-induced cell fusion by amidino compounds
US4933347A (en) 1988-10-25 1990-06-12 University Of North Carolina At Chapel Hill Diamidines and bis(imidazolines) for the treatment of and prophylaxis against pneumocystis carinii pneumonia
US4963589A (en) 1988-10-25 1990-10-16 The University Of North Carolina At Chapel Hill Methods for treating Giardia lamblia
US5428051A (en) * 1992-10-13 1995-06-27 University Of North Carolina Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
HUT71345A (en) 1993-09-22 1995-11-28 Wellcome Found Bis(amidinobenzimidazolyl)alkanes and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US6815461B1 (en) 2004-11-09
EP0739202B1 (en) 1998-12-16
ATE174508T1 (de) 1999-01-15
JP3306830B2 (ja) 2002-07-24
JPH09508369A (ja) 1997-08-26
NZ279619A (en) 1999-09-29
WO1995019772A1 (en) 1995-07-27
CA2179015C (en) 2003-06-24
DE69506686T2 (de) 1999-07-22
AU1679895A (en) 1995-08-08
CA2179015A1 (en) 1995-07-27
BR9506552A (pt) 1997-10-28
AU675386B2 (en) 1997-01-30
NZ335226A (en) 2000-11-24
EP0739202A1 (en) 1996-10-30
DE69506686D1 (de) 1999-01-28

Similar Documents

Publication Publication Date Title
ES2128043T3 (es) Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral.
AR003415A1 (es) Compuestos analogos de lactacistina, metodo para inhibir la proteolisis dependiente de proteasoma, metodo para identificar un proceso biologico mediado por proteolisis dependiente de proteasoma, uso de dichos compuestos para preparar un medicamento para tratar una condicion mediada por proteolisis dependiente de proteasoma.
BR9709823B1 (pt) "compostos de amidas de ácido alqueno piridílico e alquino piridílico, métodos de preparação e uso dos mesmos, bem como medicamento".
SE9504661D0 (sv) New compounds
RU94036758A (ru) Применение 2-фенил-3-ароилбензотиофенов для лечения пери-менопаузного синдрома
SE9401728D0 (sv) New compounds II
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
RU94044453A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей
RU94044454A (ru) Ингибитор аутоимунных заболеваний
ES2161238T3 (es) Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para inhibir la angiogenesis y enfermedades angiogenicas.
ES2154669T3 (es) Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para la inhibicion de la degradacion del cartilago.
NO20000446L (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, - salter og -komplekser
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
SE9504662D0 (sv) New compounds
IT9019793A0 (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
ATE81775T1 (de) Pharmazeutische zusammensetzungen.
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные
ATE74505T1 (de) Schmerzpraeparat.
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 739202

Country of ref document: ES